Study highlights overuse of tumor marker tests in primary and secondary care

(European Society for Medical Oncology) The vast majority of tumor marker tests in primary and secondary care are not necessary, according to a study that will be presented at the ESMO 2017 Congress in Madrid. The tests assisted with a cancer diagnosis in just 2 percent of patients.